Webcast/CME - Prevention of Infection in Rheumatoid Arthritis Patients Receiving Biologic Agents

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Vaccinology

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Vaccinology

	Immunization Fast Track 2009
	Cardiac Complications after Smallpox Vaccination
	Update on HPV: Beyond Cervical Cancer
	The Effect of Biologic Agents on Humoral Immunity: Significance of Immunoglobulins and Response to Vaccines
	Adult Preventive Health Care: Immunizations

Recent news - Vaccinology

	Varicella Vaccine Reduces Shingles Risk in Children - (DGNews)
	The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment - (BMJ)
	European Medicines Agency Reaffirms Efficacy, Safety of H1N1 Vaccines - (DGNews)
	Health Canada Approves Unadjuvanted H1N1 Vaccine - (DGNews)
	H1N1 Monovalent Vaccine Approved in Switzerland - (DGNews)

Recent cases - Vaccinology

	Vaccinations in Adults
	Minimal Change Nephrotic Syndrome in an 82 Year Old Patient Following a Tetanus-Diphteria-Poliomyelitis-Vaccination
	Exogenous Re-Infection by a Novel Streptococcus Pneumoniae Serotype 14 as a Cause of Recurrent Meningitis in a Child from the Gambia
	An Infant with Asymptomatic Hepatic Granuloma Probably Caused by Bacillus Calmette-Guerin (BCG) Vaccination Found Incidentally at Autopsy: A Case Report
	A Potentially Preventable Case of Serious Influenza Infection in a Pregnant Patient

personal edition > vaccinology > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Prevention of Infection in Rheumatoid Arthritis Patients Receiving Biologic Agents

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	Leonard H. Calabrese, DO and John J. Cush, MD
Approximate duration:	1 hr.
Summary points:	This audiovisual presentation discusses the relevant factors for managing infection risk and administration of vaccines in a patient with RA, safety data concerning the use of biologic disease-modifying antirheumatic drugs in patients with RA who are candidates for vaccination, and treatment options for vaccinated patients with RA.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Expiration date: February 6, 2010.
Other:

Additional Information